Searchable abstracts of presentations at key conferences in endocrinology

ea0063p696 | Pituitary and Neuroendocrinology 2 | ECE2019

Endoscopic transsphenoidal surgery for Cushing’s disease; a single surgeon experience

Garrahy Aoife , Brady Zarina , Sherlock Mark , Thompson Christopher J , Agha Amar , Javadpour Mohsen

Transsphenoidal surgery (TSS) to resect a corticotroph adenoma is the first-line treatment for Cushing’s disease (CD); remission rates of up to 80% have been reported in cases of microadenomas. Endocrine Society guidelines define post-operative biochemical remission as morning serum cortisol <138 nmol/L within seven days of surgery. Our practice is to use a cut-off of <50 nmol/L at day 3 post-op to indicate biochemical remission. If serum cortisol on day 3 is 50&#...